Cargando…
The case-crossover design via penalized regression
BACKGROUND: The case-crossover design is an attractive alternative to the classical case–control design which can be used to study the onset of acute events if the risk factors of interest vary in time. By comparing exposures within cases at different time periods, the case-crossover design does not...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994302/ https://www.ncbi.nlm.nih.gov/pubmed/27549803 http://dx.doi.org/10.1186/s12874-016-0197-0 |
_version_ | 1782449301678456832 |
---|---|
author | Doerken, Sam Mockenhaupt, Maja Naldi, Luigi Schumacher, Martin Sekula, Peggy |
author_facet | Doerken, Sam Mockenhaupt, Maja Naldi, Luigi Schumacher, Martin Sekula, Peggy |
author_sort | Doerken, Sam |
collection | PubMed |
description | BACKGROUND: The case-crossover design is an attractive alternative to the classical case–control design which can be used to study the onset of acute events if the risk factors of interest vary in time. By comparing exposures within cases at different time periods, the case-crossover design does not rely on control subjects which can be difficult to acquire. However, using the standard method of maximum likelihood, resulting risk estimates can be heavily biased when the prevalence to risk factors is very low (or very high). METHODS: To overcome the problem of low risk factor prevalences, penalized conditional logistic regression via the lasso (least absolute shrinkage and selection operator) has been proposed in the literature as well as related methods such as the Firth correction. We apply and compare several penalized regression approaches in the context of a case-crossover analysis of the European Study of Severe Cutaneous Adverse Reactions (EuroSCAR; 1997–2001). RESULTS: Out of 30 drugs, standard methods only correctly classified 17 drugs (including some highly implausible risk estimates), while penalized methods correctly classified 22 drugs. CONCLUSION: Penalized methods generally yield better risk classifications and much more plausible risk estimates for the EuroSCAR study than standard methods. As these novel techniques can be easily implemented using available R packages, we encourage routine use of penalized conditional logistic regression for case-crossover data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0197-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4994302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49943022016-08-24 The case-crossover design via penalized regression Doerken, Sam Mockenhaupt, Maja Naldi, Luigi Schumacher, Martin Sekula, Peggy BMC Med Res Methodol Research Article BACKGROUND: The case-crossover design is an attractive alternative to the classical case–control design which can be used to study the onset of acute events if the risk factors of interest vary in time. By comparing exposures within cases at different time periods, the case-crossover design does not rely on control subjects which can be difficult to acquire. However, using the standard method of maximum likelihood, resulting risk estimates can be heavily biased when the prevalence to risk factors is very low (or very high). METHODS: To overcome the problem of low risk factor prevalences, penalized conditional logistic regression via the lasso (least absolute shrinkage and selection operator) has been proposed in the literature as well as related methods such as the Firth correction. We apply and compare several penalized regression approaches in the context of a case-crossover analysis of the European Study of Severe Cutaneous Adverse Reactions (EuroSCAR; 1997–2001). RESULTS: Out of 30 drugs, standard methods only correctly classified 17 drugs (including some highly implausible risk estimates), while penalized methods correctly classified 22 drugs. CONCLUSION: Penalized methods generally yield better risk classifications and much more plausible risk estimates for the EuroSCAR study than standard methods. As these novel techniques can be easily implemented using available R packages, we encourage routine use of penalized conditional logistic regression for case-crossover data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0197-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-22 /pmc/articles/PMC4994302/ /pubmed/27549803 http://dx.doi.org/10.1186/s12874-016-0197-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Doerken, Sam Mockenhaupt, Maja Naldi, Luigi Schumacher, Martin Sekula, Peggy The case-crossover design via penalized regression |
title | The case-crossover design via penalized regression |
title_full | The case-crossover design via penalized regression |
title_fullStr | The case-crossover design via penalized regression |
title_full_unstemmed | The case-crossover design via penalized regression |
title_short | The case-crossover design via penalized regression |
title_sort | case-crossover design via penalized regression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994302/ https://www.ncbi.nlm.nih.gov/pubmed/27549803 http://dx.doi.org/10.1186/s12874-016-0197-0 |
work_keys_str_mv | AT doerkensam thecasecrossoverdesignviapenalizedregression AT mockenhauptmaja thecasecrossoverdesignviapenalizedregression AT naldiluigi thecasecrossoverdesignviapenalizedregression AT schumachermartin thecasecrossoverdesignviapenalizedregression AT sekulapeggy thecasecrossoverdesignviapenalizedregression AT doerkensam casecrossoverdesignviapenalizedregression AT mockenhauptmaja casecrossoverdesignviapenalizedregression AT naldiluigi casecrossoverdesignviapenalizedregression AT schumachermartin casecrossoverdesignviapenalizedregression AT sekulapeggy casecrossoverdesignviapenalizedregression |